| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | Jun 26, 2023 | Pauls Dietrich John Pres CEO | Buy | Diamedica Therapeutics Inc. | DMAC | $3.91 | $49,997 | +15.71% |
| Nov 16, 2022 | Nov 17, 2022 | Pauls Dietrich John Pres CEO | Buy | Diamedica Therapeutics Inc. | DMAX | $1.21 | $24,200 | +26.38% |
| Aug 16, 2021 | Aug 16, 2021 | Pauls Dietrich John Pres CEO | Buy | Diamedica Therapeutics Inc. | DMAC | $3.14 | $15,700 | +12.25% |
| Aug 16, 2019 | Aug 16, 2019 | Pauls Dietrich John Pres CEO | Buy | Diamedica Therapeutics Inc. | DMAC | $2.68 | $2,677 | +3.14% |
| Dec 11, 2018 | Dec 11, 2018 | Pauls Dietrich John Pres CEO | Buy | Diamedica Therapeutics Inc. | DMAC | $4 | $20,000 | +14.37% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.